ArticleOphthalmology2023
Training Deep Learning Models to Work on Multiple Devices by Cross-Domain Learning with No Additional Annotations.
Article in Ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.
- Ophthalmic Image Synthesis and Analysis with Generative Adversarial Network Artificial Intelligence.Journal of imaging informatics in medicine · 2026Pooled it
- Improving Generalization of Deep Learning for Glaucoma Classification Under Real-World Domain Shift via Unsupervised Domain Adaptation.Translational vision science & technology · 2026Article
- Initiation of a global consortium to study the progression of age-related macular degeneration: RIMR AMD consortium report # 1.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- DPLSeg: unsupervised general segmentation model for retinal images across multiple OCT devices.Biomedical optics express · 2026Article
- Beyond convolutions and supervised learning with transformers and representation learning for retinal image analysis.Progress in retinal and eye research · 2026Review
- Generative Artificial Intelligence for Retinal Image Translation to Improve Glaucoma Screening With Deep Learning.Translational vision science & technology · 2025Article
- Diagnostic Accuracy of 3D Deep Learning Classifiers for Glaucoma Detection: A Comparison of Cross-Domain and Device-Specific Models.Translational vision science & technology · 2025Article
- Recent Optical Coherence Tomography (OCT) Innovations for Increased Accessibility and Remote Surveillance.Bioengineering (Basel, Switzerland) · 2025Review
- A Future Picture: A Review of Current Generative Adversarial Neural Networks in Vitreoretinal Pathologies and Their Future Potentials.Biomedicines · 2025Review
- Cross-instrument optical coherence tomography-angiography (OCTA)-based prediction of age-related macular degeneration (AMD) disease activity using artificial intelligence.Scientific reports · 2024Article
- A Clinician's Guide to Sharing Data for AI in Ophthalmology.Investigative ophthalmology & visual science · 2024Review
- Automated deep learning-based AMD detection and staging in real-world OCT datasets (PINNACLE study report 5).Scientific reports · 2023Article
- Deep learning in optical coherence tomography: Where are the gaps?Clinical & experimental ophthalmology · 2023Review
- Artificial Intelligence for Diabetic Retinopathy Screening Using Color Retinal Photographs: From Development to Deployment.Ophthalmology and therapy · 2023Review
- A Practical Guide to Evaluating Artificial Intelligence Imaging Models in Scientific Literature.Ophthalmology scienceArticle
- Validation of Deep Learning-Based Automatic Retinal Layer Segmentation Algorithms for Age-Related Macular Degeneration with 2 Spectral-Domain OCT Devices.Ophthalmology scienceArticle
- American Society of Retina Specialists Artificial Intelligence Task Force Report.Journal of vitreoretinal diseasesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 2 institutions in 2 countries.
Funding
Abstract
purposeTo create an unsupervised cross-domain segmentation algorithm for segmenting intraretinal fluid and retinal layers on normal and pathologic macular OCT images from different manufacturers and camera devices.
designWe sought to use generative adversarial networks (GANs) to generalize a segmentation model trained on one OCT device to segment B-scans obtained from a different OCT device manufacturer in a fully unsupervised approach without labeled data from the latter manufacturer.
participantsA total of 732 OCT B-scans from 4 different OCT devices (Heidelberg Spectralis, Topcon 1000, Maestro2, and Zeiss Plex Elite 9000).
methodsWe developed an unsupervised GAN model, GANSeg, to segment 7 retinal layers and intraretinal fluid in Topcon 1000 OCT images (domain B) that had access only to labeled data on Heidelberg Spectralis images (domain A). GANSeg was unsupervised because it had access only to 110 Heidelberg labeled OCTs and 556 raw and unlabeled Topcon 1000 OCTs. To validate GANSeg segmentations, 3 masked graders manually segmented 60 OCTs from an external Topcon 1000 test dataset independently. To test the limits of GANSeg, graders also manually segmented 3 OCTs from Zeiss Plex Elite 9000 and Topcon Maestro2. A U-Net was trained on the same labeled Heidelberg images as baseline. The GANSeg repository with labeled annotations is at https://github.com/uw-biomedical-ml/ganseg.
main outcome measuresDice scores comparing segmentation results from GANSeg and the U-Net model with the manual segmented images.
resultsAlthough GANSeg and U-Net achieved comparable Dice scores performance as human experts on the labeled Heidelberg test dataset, only GANSeg achieved comparable Dice scores with the best performance for the ganglion cell layer plus inner plexiform layer (90%; 95% confidence interval [CI], 68%-96%) and the worst performance for intraretinal fluid (58%; 95% CI, 18%-89%), which was statistically similar to human graders (79%; 95% CI, 43%-94%). GANSeg significantly outperformed the U-Net model. Moreover, GANSeg generalized to both Zeiss and Topcon Maestro2 swept-source OCT domains, which it had never encountered before.
conclusionsGANSeg enables the transfer of supervised deep learning algorithms across OCT devices without labeled data, thereby greatly expanding the applicability of deep learning algorithms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.